184 related articles for article (PubMed ID: 11444927)
21. The role of A1/A3 adenosine receptor activation in reduction of cardiomyocyte injury caused by hypoxic stress and in induction of apoptosis in rat cardiomyocyte cultures.
Shainberg A; Safran N; Balas N; Zinman T; Isaac A; Schwab K; Akabayov B; Shneyvays V
Adv Exp Med Biol; 2000; 486():201-5. PubMed ID: 11783485
[No Abstract] [Full Text] [Related]
22. The adenosine receptor agonist, APNEA, increases calcium influx into rat cortical synaptosomes through N-type channels associated with A2a receptors.
Li SN; Wong PT
Neurochem Res; 2000 Apr; 25(4):457-9. PubMed ID: 10823578
[TBL] [Abstract][Full Text] [Related]
23. Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement.
Armstrong S; Ganote CE
Cardiovasc Res; 1994 Jul; 28(7):1049-56. PubMed ID: 7525060
[TBL] [Abstract][Full Text] [Related]
24. Adenosine A(3) receptor activation protects the myocardium from reperfusion/reoxygenation injury.
Maddock HL; Mocanu MM; Yellon DM
Am J Physiol Heart Circ Physiol; 2002 Oct; 283(4):H1307-13. PubMed ID: 12234780
[TBL] [Abstract][Full Text] [Related]
25. Balance of purines may determine life or death of retinal ganglion cells as A3 adenosine receptors prevent loss following P2X7 receptor stimulation.
Zhang X; Zhang M; Laties AM; Mitchell CH
J Neurochem; 2006 Jul; 98(2):566-75. PubMed ID: 16805847
[TBL] [Abstract][Full Text] [Related]
26. A role for histamine in cytokine modulation by the adenosine A(3) receptor agonist, 2-Cl-IB-MECA.
Smith SR; Denhardt G; Terminelli C
Eur J Pharmacol; 2002 Dec; 457(1):57-69. PubMed ID: 12460644
[TBL] [Abstract][Full Text] [Related]
27. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
Mlejnek P; Dolezel P; Kosztyu P
J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
[TBL] [Abstract][Full Text] [Related]
28. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA
J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166
[TBL] [Abstract][Full Text] [Related]
29. Anti-adrenergic effect of adenosine on Na(+)-Ca(2+) exchange current recorded from guinea-pig ventricular myocytes.
Zhang YH; Hinde AK; Hancox JC
Cell Calcium; 2001 May; 29(5):347-58. PubMed ID: 11292391
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells.
Suh BC; Kim TD; Lee JU; Seong JK; Kim KT
Br J Pharmacol; 2001 Sep; 134(1):132-42. PubMed ID: 11522605
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of alpha(1)-adrenergic-mediated responses in rat ventricular myocytes by adenosine A(1) receptor activation: role of the K(ATP) channel.
Hoque N; Cook MA; Karmazyn M
J Pharmacol Exp Ther; 2000 Aug; 294(2):770-7. PubMed ID: 10900259
[TBL] [Abstract][Full Text] [Related]
32. A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study.
Gessi S; Varani K; Merighi S; Cattabriga E; Iannotta V; Leung E; Baraldi PG; Borea PA
Mol Pharmacol; 2002 Feb; 61(2):415-24. PubMed ID: 11809867
[TBL] [Abstract][Full Text] [Related]
33. Species-dependent hemodynamic effects of adenosine A3-receptor agonists IB-MECA and Cl-IB-MECA.
Lasley RD; Narayan P; Jahania MS; Partin EL; Kraft KR; Mentzer RM
Am J Physiol; 1999 Jun; 276(6):H2076-84. PubMed ID: 10362690
[TBL] [Abstract][Full Text] [Related]
34. Roles of BCL-2 and caspase 3 in the adenosine A3 receptor-induced apoptosis.
Appel E; Kazimirsky G; Ashkenazi E; Kim SG; Jacobson KA; Brodie C
J Mol Neurosci; 2001 Dec; 17(3):285-92. PubMed ID: 11859924
[TBL] [Abstract][Full Text] [Related]
35. Adenosine A3 receptor agonists protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists.
Yao Y; Sei Y; Abbracchio MP; Jiang JL; Kim YC; Jacobson KA
Biochem Biophys Res Commun; 1997 Mar; 232(2):317-22. PubMed ID: 9125172
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of ANP secretion by 2-Cl-IB-MECA through A(3) receptor and CaMKII.
Yuan K; Bai GY; Park WH; Kim SZ; Kim SH
Peptides; 2008 Dec; 29(12):2216-24. PubMed ID: 18838091
[TBL] [Abstract][Full Text] [Related]
37. Differential allosteric modulation by amiloride analogues of agonist and antagonist binding at A(1) and A(3) adenosine receptors.
Gao ZG; Melman N; Erdmann A; Kim SG; Müller CE; IJzerman AP; Jacobson KA
Biochem Pharmacol; 2003 Feb; 65(4):525-34. PubMed ID: 12566079
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 does not mediate late preconditioning induced by activation of adenosine A1 or A3 receptors.
Kodani E; Shinmura K; Xuan YT; Takano H; Auchampach JA; Tang XL; Bolli R
Am J Physiol Heart Circ Physiol; 2001 Aug; 281(2):H959-68. PubMed ID: 11454603
[TBL] [Abstract][Full Text] [Related]
39. Effects of A(3) adenosine receptor activation and gene knock-out in ischemic-reperfused mouse heart.
Harrison GJ; Cerniway RJ; Peart J; Berr SS; Ashton K; Regan S; Paul Matherne G; Headrick JP
Cardiovasc Res; 2002 Jan; 53(1):147-55. PubMed ID: 11744023
[TBL] [Abstract][Full Text] [Related]
40. Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus.
Dunwiddie TV; Diao L; Kim HO; Jiang JL; Jacobson KA
J Neurosci; 1997 Jan; 17(2):607-14. PubMed ID: 8987783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
